Is this the perfect FTSE 100 stock to own right now?

Finding FTSE 100 stocks that offer a nice mix of growth potential and resilience isn’t that easy. But here’s one I think ticks both boxes.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Picking FTSE 100 stocks to invest within the current environment has its challenges. On one hand, you want to be investing in companies that are set for solid growth in the years ahead. On the other, you also want an element of defensiveness. Economic uncertainty remains extremely elevated due to Covid-19 and we can’t rule out a second stock market crash.

Finding FTSE stocks that offer a nice mix of growth potential and resilience isn’t that easy. There are some stocks, however, that tick both boxes. Here’s a look at one such stock I like the look of right now.

The perfect FTSE 100 stock to own?

Reckitt Benckiser (LSE: RB) is a leading FTSE 100 consumer goods company that focuses on health and hygiene products. It owns a leading portfolio of brands that are sold in nearly 200 countries and are trusted by millions of people worldwide. Its major brands include the likes of Dettol, Lysol, Finish, and Nurofen.

Growth potential in a post-Covid-19 world

In terms of growth potential, I see Reckitt Benckiser as very well-placed in a post-Covid-19 world. Given that we’re all likely to be far more focused on hygiene, demand for Reckitt’s products, such as Dettol antibacterial soaps and wipes, and Lysol disinfectant sprays, should be high. I’ll point out that in the first quarter of 2020, Reckitt reported like-for-like growth of 12.8% in its hygiene division with strong growth in most markets. That’s certainly encouraging.

There are other growth drivers here too. One is the world’s ageing population. With the number of over 60s worldwide set to rise to 1.4bn by 2030, up from 901m five years ago, I can see demand for RB’s trusted healthcare products such as Nurofen, Gaviscon, and Mucinex steadily rising in the years ahead too.

Overall, Reckitt Benckiser appears to have plenty of growth potential, in my view.

A resilient FTSE company

At the same time, Reckitt Benckiser can also offer investors portfolio protection. If the global economy does experience a prolonged recession due to Covid-19, you can be sure Reckitt will survive. That’s because it sells everyday products that people tend to buy, no matter what the economy is doing.

And if the stock market crashes again, RB is likely to provide portfolio stability. In the recent crash, the stock only fell 20%, versus a decline of around 35% for the FTSE 100 index.

Reliable dividend payer

On top of all this, Reckitt Benckiser is a very reliable dividend payer. Since the FTSE 100 company was formed in 1999, it has never cut its dividend. And in that time, the company has lifted its payout from 24p per share to 175p per share. Currently, the prospective dividend yield is about 2.4%.

Putting this all together, Reckitt Benckiser has a lot going for it, in my opinion.

Long-term buy-and-hold

However, I’ll point out that Reckitt Benckiser shares aren’t super-cheap. With analysts forecasting earnings of 310p per share this year, the forward-looking P/E ratio is about 24. But I wouldn’t let that valuation put you off. Recently, Barclays raised its target price for the stock to 9,000p – 20% higher than the current share price.

All things considered, I believe RB is the perfect stock to own right now. I’d buy the FTSE 100 stock today and hold it for the long term.

Edward Sheldon owns shares in Reckitt Benckiser. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

A 2026 stock market crash could be a rare passive income opportunity

If a stock market crash comes our way then it might throw up plentiful opportunities for investors to secure a…

Read more »

Tesla car at super charger station
Investing Articles

£10,000 invested in Tesla stock 1 year ago is now worth…

Dr James Fox takes a closer look at Tesla stock with the incredibly volatile mega-cap company surging and pulling back…

Read more »

British pound data
Investing Articles

My personal warning for anyone tempted by the plunging Aston Martin share price

Harvey Jones was so captivated by the plunging Aston Martin share price that he ignored an old piece of investment…

Read more »

Stacks of coins
Investing Articles

This penny share just crashed 13% to 19p! Time to buy?

After another fall today, this penny stock has now crashed 70% since April 2021. Is it one that should be…

Read more »

Trader on video call from his home office
Investing Articles

Down 19%! Here’s why Barclays shares look a serious bargain to me right now

Barclays shares have slumped recently, but a big gap between price and fair value has opened, offering nimble long-term investors…

Read more »

CEO Mark Zuckerberg at F8 2019 event
Investing Articles

Why Meta Platforms shares fell 12.5% in March

Historically, investors have done well by buying Meta Platforms shares when the price has fallen. But is the latest legal…

Read more »

Arrow symbol glowing amid black arrow symbols on black background.
Investing Articles

£20,000 invested in BAE Systems shares 4 years ago is now worth…

BAE Systems' shares have soared since 2022, yet rising NATO budgets are just starting to feed through, so the real…

Read more »

This way, That way, The other way - pointing in different directions
Investing For Beginners

Aviva shares fell 12% in March! Here’s my outlook from here

Jon Smith explains why Aviva shares underperformed last month, but paints an upbeat picture for the stock when looking further…

Read more »